Available Research Fellow Position
Research Fellow positions
We are looking for a Research Fellow to support the development of an enzyme-responsive peptide-mimetic hydrogel for the sustained parenteral delivery of antiretroviral drugs for HIV/AIDs. This is an MRC funded project with support available for a one year post (until 30 June 2021).
Deadline: Monday 15th June 2020
Salary: £33,797 – £36,914 per annum
We cannot accept applications directly via email, they must go through the University’s HR system. Please apply using link below.
The successful candidate will design, synthesise and characterise peptide-mimetic hydrogelator platforms suitable for the sustained parenteral delivery of antiretroviral drugs. Such techniques will include solid/liquid phase peptoid synthesis and purification, formulation, microscopy (TEM, SEM), spectroscopy (FTIR, CD, UV/Vis, NMR, Mass spectroscopy), oscillatory rheology, cell culture and drug release (HPLC).
The successful Research Fellow must have:
- Or be about to obtain a PhD in Chemistry, Biochemistry, Chemical Engineering, Pharmaceutical Chemistry, Pharmaceutical Sciences or closely related area.
- At least 3 years recent relevant practical research experience of peptoid and peptide-mimetic synthesis, advanced methods of drug conjugation, purification and identification.
- Experience in formulating peptide-mimetic hydrogel systems.
- Experience in drug purification, release experiments and quantification by HPLC.
Advanced Science News Coverage and Advanced Healthcare Materials paper
Our recent research into using peptide hydrogels as long-acting injectable implants for HIV/AIDS drug delivery has be covered by Advanced Science News. This provides an oversight of our most recent publication within Advanced Healthcare Materials. A link to both can be found below: Advanced Science News Advanced Healthcare Materials
Our EPSRC research selected as case study
Our research into long-acting peptide hydrogel drug delivery implants has been selected as a case study by the EPSRC for their Developing New Therapies Grand Challenge. Thanks to all of those involved in this multidisciplinary project and it’s great to see our work moving forward towards future use in patients. Please find a link to the […]
Group receive major funding from EPSRC to develop peptide-like hydrogels for combined HIV-contraceptive therapy
We are excited to announce support from the Engineering and Physical Sciences Research Council (EPSRC) to develop of peptide-like hydrogels for use as a long-acting injectable delivery platform for combined HIV-contraceptive drug delivery. Total support (£766,542) will allow further development of our peptide-mimetic platforms in a key healthcare area in collaboration with our co-investigators at […]
Funding for Medical Research Council: Confidence in Concept Project
We are happy to announce our group has received funding as part of the MRC CiC programme (£67,867) to study the use of antiretroviral drugs in HIV/AIDs prevention alongside our industry partners. Funding will enable a Research Fellow to work within our group on this project for one year. We should hopefully be in a […]
Latest paper from group: Investigating the In Vivo Antimicrobial Activity of a Self-Assembling Peptide Hydrogel Using a Galleria mellonella Infection Model
Our latest research paper is now freely available via the journal ACS Omega, whereby we use an innovative waxworm (Galleria mellonella) model as an alternative to mammalian/vertebrate testing. The following assay can be very simply performed without any specific ethical approval or animal licenses. We successfully employed the methods outlined to study the antimicrobial efficacy […]